Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability
Authors
Keywords
Anti-osteoporotic treatment, Bone turnover markers, C-terminal telopeptide of type I collagen, N-terminal propeptide of type I procollagen, Osteoporosis
Journal
OSTEOPOROSIS INTERNATIONAL
Volume 28, Issue 9, Pages 2541-2556
Publisher
Springer Nature
Online
2017-06-19
DOI
10.1007/s00198-017-4082-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Postprandial response of bone turnover markers in patients with Crohn’s disease
- (2017) Ioannis Karatzoglou et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Adalimumab Therapy Has a Beneficial Effect on Bone Metabolism in Patients with Crohn’s Disease
- (2015) Sundaram G. Veerappan et al. DIGESTIVE DISEASES AND SCIENCES
- Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women?
- (2015) Pascale Chavassieux et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Bone turnover markers in Paget’s disease of the bone: A Systematic review and meta-analysis
- (2015) A. A. Al Nofal et al. OSTEOPOROSIS INTERNATIONAL
- THU0390 Effect of Glucocorticoid Treatment on Wnt Signalling Antagonists (Sclerostin and Dkk-1) and their Relationship to Bone Turnover and Bone Mass
- (2014) L. Gifre et al. ANNALS OF THE RHEUMATIC DISEASES
- The association between critical illness and changes in bone turnover in adults: a systematic review
- (2014) N. Orford et al. OSTEOPOROSIS INTERNATIONAL
- PINP as a biological response marker during teriparatide treatment for osteoporosis
- (2014) J. H. Krege et al. OSTEOPOROSIS INTERNATIONAL
- Aminoterminal propeptide of type I procollagen (PINP) in chronic kidney disease patients: the assay matters.
- (2013) Etienne Cavalier et al. CLINICA CHIMICA ACTA
- IDS iSYS automated intact procollagen-1-N-terminus pro-peptide assay: method evaluation and reference intervals in adults and children
- (2013) Alireza Morovat et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Vitamin D Status and Indices of Bone Turnover in Older European Adults
- (2013) Kelly M. Seamans et al. INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH
- Effect of ONO-5334 on Bone Mineral Density and Biochemical Markers of Bone Turnover in Postmenopausal Osteoporosis: 2-Year Results From the OCEAN Study
- (2013) Richard Eastell et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Reference values of osteocalcin and procollagen type I N-propeptide plasma levels in a healthy Central European population aged 0–18 years
- (2013) M. Bayer OSTEOPOROSIS INTERNATIONAL
- Odanacatib, a selective cathepsin K inhibitor to treat osteoporosis: safety, tolerability, pharmacokinetics and pharmacodynamics - results from single oral dose studies in healthy volunteers
- (2012) S. Aubrey Stoch et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Blood biochemical markers of bone turnover: pre-analytical and technical aspects of sample collection and handling
- (2012) Giovanni Lombardi et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- High-calcium, vitamin D fortified milk is effective in improving bone turnover markers and vitamin D status in healthy postmenopausal Chinese women
- (2012) M C Kruger et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- Distinct effects of pioglitazone and metformin on circulating sclerostin and biochemical markers of bone turnover in men with type 2 diabetes mellitus
- (2012) A H van Lierop et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Bone Effects of Rosiglitazone in HIV-Infected Patients With Lipoatrophy
- (2012) Allison C. Ross et al. HIV CLINICAL TRIALS
- Prospective Follow-Up of Novel Markers of Bone Turnover in Persistent Asthmatics Exposed to Low and High Doses of Inhaled Ciclesonide over 12 Months
- (2012) W. J. Anderson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Evaluation of Markers of Bone Turnover During Lactation in African-Americans: A Comparison With Caucasian Lactation
- (2012) Raquel M. Carneiro et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Bone turnover markers: use in osteoporosis
- (2012) Kim Naylor et al. Nature Reviews Rheumatology
- Prevalence and seasonal variation of hypovitaminosis D and its relationship to bone metabolism in healthy Hungarian men over 50 years of age: the HunMen Study
- (2012) H. P. Bhattoa et al. OSTEOPOROSIS INTERNATIONAL
- National Bone Health Alliance Bone Turnover Marker Project: current practices and the need for US harmonization, standardization, and common reference ranges
- (2012) D. Bauer et al. OSTEOPOROSIS INTERNATIONAL
- IL-6 Receptor Inhibition Positively Modulates Bone Balance in Rheumatoid Arthritis Patients with an Inadequate Response to Anti-Tumor Necrosis Factor Therapy: Biochemical Marker Analysis of Bone Metabolism in the Tocilizumab RADIATE Study (NCT00106522)
- (2012) Morten A. Karsdal et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Effects of ONO-5334, a novel orally-active inhibitor of cathepsin K, on bone metabolism
- (2011) Yasuo Ochi et al. BONE
- Roadmap for Harmonization of Clinical Laboratory Measurement Procedures
- (2011) W. Greg Miller et al. CLINICAL CHEMISTRY
- The effect of topiramate monotherapy on bone mineral density and markers of bone and mineral metabolism in premenopausal women with epilepsy
- (2011) Kyoung Heo et al. EPILEPSIA
- The effect of timing of teriparatide treatment on the circadian rhythm of bone turnover in postmenopausal osteoporosis
- (2011) Maria Luchavova et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Prednisone affects inflammation, glucose tolerance, and bone turnover within hours of treatment in healthy individuals
- (2011) Eunkyung Kauh et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Changes in bone turnover markers during the close season in elite football (soccer) players
- (2011) Richard Weiler et al. JOURNAL OF SCIENCE AND MEDICINE IN SPORT
- Rapid Onset and Sustained Efficacy (ROSE) study: results of a randomised, multicentre trial comparing the effect of zoledronic acid or alendronate on bone metabolism in postmenopausal women with low bone mass
- (2011) P. Hadji et al. OSTEOPOROSIS INTERNATIONAL
- The effect of high-dose vitamin D on bone mineral density and bone turnover markers in postmenopausal women with low bone mass—a randomized controlled 1-year trial
- (2011) G. Grimnes et al. OSTEOPOROSIS INTERNATIONAL
- Validation of an automated intact N-terminal propeptide of type I procollagen (PINP) assay
- (2010) Marja-Kaisa Koivula et al. CLINICAL BIOCHEMISTRY
- Procollagen I amino-terminal propeptide as a potential marker for multiple myeloma
- (2010) Maria Kowalska et al. CLINICAL BIOCHEMISTRY
- The Effects of Sampling Procedures and Storage Conditions on Short-term Stability of Blood-Based Biochemical Markers of Bone Metabolism
- (2010) F. J. Stokes et al. CLINICAL CHEMISTRY
- Multiple myeloma: changes in serum C-terminal telopeptide of collagen type I and bone-specific alkaline phosphatase can be used in daily practice to detect imminent osteolysis*
- (2010) Thomas Lund et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Bone Mass and Bone Metabolism Markers during Adolescence: The HELENA Study
- (2010) L. Gracia-Marco et al. Hormone Research in Paediatrics
- TRACP 5b and CTX as osteological markers of delayed fracture healing
- (2010) A. Moghaddam et al. INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED
- Utility of type I procollagen propeptide assays for assessing abnormalities in metabolic bone diseases
- (2010) Peter R. Ebeling et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of denosumab on bone turnover markers in postmenopausal osteoporosis
- (2010) Richard Eastell et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Lactation and Bone Turnover: A Conundrum of Marked Bone Loss in the Setting of Coupled Bone Turnover
- (2010) Raquel M. Carneiro et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Relative Influence of Calcium Intake and Vitamin D Status on Serum Parathyroid Hormone and Bone Turnover Biomarkers in a Double-Blind, Placebo-Controlled Parallel Group, Longitudinal Factorial Design
- (2010) John Aloia et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Bone turnover markers and bone mineral density in hypertensive postmenopausal women on treatment
- (2010) José M. Olmos et al. MATURITAS
- Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards
- (2010) S. Vasikaran et al. OSTEOPOROSIS INTERNATIONAL
- Rapid and sustained improvement in bone and cartilage turnover markers with the antiâinterleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: Results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alone
- (2009) Patrick Garnero et al. ARTHRITIS AND RHEUMATISM
- A study of the effects of the aromatase inhibitors anastrozole and letrozole on bone metabolism in postmenopausal women with estrogen receptor-positive breast cancer
- (2009) Fiona M. McCaig et al. BREAST CANCER RESEARCH AND TREATMENT
- Efficacy and tolerability of once-monthly oral ibandronate (150 mg) and once-weekly oral alendronate (70 mg): Additional results from the monthly oral therapy with ibandronate for osteoporosis intervention (MOTION) study
- (2009) Ronald Emkey et al. CLINICAL THERAPEUTICS
- Relationships of Serum 25-Hydroxyvitamin D to Bone Mineral Density and Serum Parathyroid Hormone and Markers of Bone Turnover in Older Persons
- (2009) Natalia O. Kuchuk et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes
- (2009) Bernard Zinman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Bone turnover marker profile in relation to the menstrual cycle of premenopausal healthy women
- (2009) Margery L. Gass et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Monthly ibandronate suppresses serum CTX-I within 3 days and maintains a monthly fluctuating pattern of suppression
- (2009) N. Binkley et al. OSTEOPOROSIS INTERNATIONAL
- Depot medroxyprogesterone acetate use after peak bone mass is associated with increased bone turnover but no decrease in bone mineral density
- (2008) Jennifer S. Walsh et al. FERTILITY AND STERILITY
- Randomized Controlled Trial of the Effects of Calcium With or Without Vitamin D on Bone Structure and Bone-Related Chemistry in Elderly Women With Vitamin D Insufficiency
- (2008) Kun Zhu et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Establishing a Reference Interval for Bone Turnover Markers in 637 Healthy, Young, Premenopausal Women From the United Kingdom, France, Belgium, and the United States
- (2008) Sarah J Glover et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis
- (2008) P. Szulc et al. OSTEOPOROSIS INTERNATIONAL
- Reduced bone mass and increased bone turnover in postmenopausal women with epilepsy using antiepileptic drug monotherapy
- (2008) Merete Alice Lyngstad‐Brechan et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis
- (2007) Pierre D. Delmas et al. BONE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started